ロード中...
Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
Ovarian cancer is a highly deadly malignancy in which recurrence is considered incurable. Resistance to platinum-based chemotherapy bodes a particularly abysmal prognosis, underscoring the need for novel therapeutic agents and strategies. The use of mithramycin, an antineoplastic antibiotic, has bee...
保存先:
| 出版年: | Biomedicines |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7828137/ https://ncbi.nlm.nih.gov/pubmed/33445667 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9010070 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|